Every case of TB started as a contact to a person with active pulmonary or laryngeal TB disease. For this reason, it is essential to identify, examine, evaluate, and treat all persons who are at risk of infection with Mycobacterium tuberculosis (m. tb) due to recent exposure to a newly diagnosed or suspected case of pulmonary or laryngeal TB.
- Guidelines for the Investigation of Contacts of Persons with Infectious Tuberculosis by the CDC, MMWR, December 16, 200
- CDC: General Information about TB Blood Tests (IGRAs)
- TB Transmission: Effect of Index Patient Characteristics and Behaviors
Contact Investigation Forms and Tools
- Tools to Assist in Need for Contact Investigation and Prioritizing Response
- Guidelines for Estimating the Start of the Infectious Period
- Contact Registration Form
- Form TB 502 instructions and timeline for submission
- Summary Report of a TB Contact Investigation in a Congregate Setting
Latent Tuberculosis Infection (LTBI)
Information from the Centers for Disease Control and Prevention (CDC) on TB Testing and Diagnosis:
Testing & Diagnosis
Mantoux Tuberculin Skin Testing Products – training resources on administering and reading the Mantoux tuberculin skin test.